Search results for: Adrian Towse
Filter search results
Cost-effectiveness Analysis of Gene Therapies for Inherited Eye Disease: Are Current Discounting Approaches Too Short-sighted?
15 February 2023
…Evaluation Reference Case to Gene Therapy. Value Health. 2019;22(6):661-668. doi:10.1016/j.jval.2019.03.012 Jönsson B, Hampson G, Michaels J, Towse A, von der Schulenburg JMG, Wong O. Advanced therapy medicinal products and health…
Breaking the European Deadlock: Part 2 – Transferable Exclusivity Vouchers – Effective Pull Incentive or a Policy Distraction?
4 January 2024
…antibiotics, targeted at WHO priority pathogens, is likely to yield a high return (Silverman Bonnifield and Towse, 2022 ). Any version of TEV will be more efficient than the current status…
Press Release: Proposed International Price Index Effectively Outsources Pharmaceutical Policy Decisions to Other Countries
29 October 2019
…SW1E 6QT ohegeneral@ohe.org For interview requests, please contact atowse@ohe.org Notes to Editors: [1] The Trump Administration proposal would compare the U.S. to the other G7 countries (Canada, France, Germany, Italy,…
The Impact of Biosimilars on Markets
24 May 2010
…the publication. Publication now available for download: Mattison, N., Mestre-Ferrandiz, J. and Towse, A. eds (2010) Biosimilars: How much entry and price competition will result? London: Office of Health Economics….
Biosimilars: Issues Overview
1 June 2010
…the Stockholm School of Economics. Publication now available for download: Mattison, N., Mestre-Ferrandiz, J. and Towse, A. eds (2010) Biosimilars: How much entry and price competition will result? London: Office…
Biosimilars and Data Exclusivity
8 June 2010
…Duke University. Publication now available for download: Mattison, N., Mestre-Ferrandiz, J. and Towse, A. eds (2010) Biosimilars: How much entry and price competition will result? London: Office of Health Economics….
Price Competition and Biosimilars
23 June 2010
…Human Services. Publication now available for download: Mattison, N., Mestre-Ferrandiz, J. and Towse, A. eds (2010) Biosimilars: How much entry and price competition will result? London: Office of Health Economics….
Biosimilars’ Price Dynamic in Europe
30 June 2010
…and Partners. Publication now available for download: Mattison, N., Mestre-Ferrandiz, J. and Towse, A. eds (2010) Biosimilars: How much entry and price competition will result? London: Office of Health Economics….
EU Approval of Biosimilars
8 July 2010
…working parties. Publication now available for download: Mattison, N., Mestre-Ferrandiz, J. and Towse, A. eds (2010) Biosimilars: How much entry and price competition will result? London: Office of Health Economics….